株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ドラッグデリバリー技術の世界市場:2018-2028の予測

Drug Delivery Technologies Market Forecast 2018-2028

発行 Visiongain Ltd 商品コード 233148
出版日 ページ情報 英文 188 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=155.30円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
ドラッグデリバリー技術の世界市場:2018-2028の予測 Drug Delivery Technologies Market Forecast 2018-2028
出版日: 2018年02月01日 ページ情報: 英文 188 Pages
概要

世界のドラッグデリバリー技術市場の収益額は、2018年に2,177億米ドルに達することが予測されています。大手製薬企業によるトップセラー商品の差別化や、患者に優しい治療法の需要などが当市場の高成長に寄与する見通しです。

当レポートでは、世界のドラッグデリバリー技術 (薬物送達技術) 技術市場を取り上げ、主要なドラッグデリバリー技術、2次市場および主要国市場における動向および予測を提示するとともに、主要企業のプロファイル、SWOT分析および専門家の見解をまとめています。

第1章 レポートの概要

  • 世界のドラッグデリバリー技術 (薬物送達技術) 市場の概要
  • 世界のドラッグデリバリー技術市場の区分
  • 当レポートを推奨する理由
  • 当レポートの提供方法
  • この解析レポートが解明する主な疑問
  • 対象読者
  • 調査手法
  • よく聞かれる質問 (FAQ)
  • 関連レポート
  • Visiongainについて

第2章 ドラッグデリバリー技術:イントロダクション

  • ドラッグデリバリー技術 (DDT) :従来型治療薬を改善するための戦略
  • 世界のドラッグデリバリー技術市場:投与手段
  • 米国における規制
  • 生物製剤 (バイオ医薬品)
  • 市場の定義

第3章 ドラッグデリバリー技術:世界市場

  • 世界のドラッグデリバリー技術市場
  • 世界のドラッグデリバリー技術市場予測
  • ドラッグデリバリー技術:促進因子・阻害因子
  • 生物製剤:ドラッグデリバリー技術における成長促進因子
    • 世界の生物製剤市場予測
    • 生物製剤の主要クラス
    • モノクロナール抗体:生物製剤における最大部門
    • ヒトインスリン:主要な治療タンパク質セグメント
    • 肝炎治療向けのインターフェロン製品
  • ワクチン:アンメットニーズへの対応
    • 世界のワクチン市場予測

第4章 ドラッグデリバリー技術の2次市場

  • 世界のドラッグデリバリー技術市場:2次市場別
  • セグメント別の市場シェアの推移予測
  • 経口薬デリバリー技術
    • 経口薬デリバリー技術市場の予測
    • 動向・発展
    • 経口薬デリバリー技術:促進因子・抑制因子
  • 吸入薬デリバリー技術
  • 注射/インプラントデリバリー技術
  • 経皮薬デリバリー技術
  • 眼薬デリバリー技術
  • 経鼻/口腔薬デリバリー技術

第5章 ドラッグデリバリー技術:主要国市場

  • 世界のドラッグデリバリー技術市場:地域別の予測
    • 市場シェアの推移予測
  • 米国のドラッグデリバリー技術市場
    • 市場予測
    • Eli Lilly はドラッグデリバリーセンターを設立
  • EU5カ国のドラッグデリバリー技術市場
    • 市場予測
    • 各国のCAGR
    • 各国の市場シェア推移予測
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
  • 日本のドラッグデリバリー技術市場
    • 市場予測
    • 先駆け審査指定制度が革新的な薬剤開発を加速
  • 中国のドラッグデリバリー技術市場
    • 市場予測
  • インドのドラッグデリバリー技術市場
    • 市場予測
  • ブラジルのドラッグデリバリー技術市場
    • 市場予測
  • ロシアのドラッグデリバリー技術市場
    • 市場予測
  • 韓国のドラッグデリバリー技術市場
    • 市場予測
  • メキシコのドラッグデリバリー技術市場
    • 市場予測
  • その他のドラッグデリバリー技術市場

第6章 ドラッグデリバリー技術市場における主要企業

  • Alkermes
  • 3M
  • Becton Dickinson and Company
  • Intercell AG
  • Altea Therapeutics Corporation
  • Antares Pharma
  • pSivida
  • Applied Pharma Research
  • Ethypharm
  • Glycologic
  • NanoPass Technologies

第7章 ドラッグデリバリー技術市場の定性分析

  • ドラッグデリバリー技術市場のSWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威

第8章 総括

  • 世界のドラッグデリバリー技術市場
    • 現在の主なドラッグデリバリー技術区分
    • 注目のドラッグデリバリー技術企業
    • 主な地域/国市場
  • 世界のドラッグデリバリー技術市場予測
  • ドラッグデリバリー技術市場の将来
    • 経皮薬・注射薬デリバリー技術が高成長の構え
    • 生物薬剤・バイオシミラーは市場成長を促進

第9章 用語

目次
Product Code: PHA0282

Title:
DRUG DELIVERY TECHNOLOGIES MARKET FORECAST 2018-2028
Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies.

What can be expected from the Drug Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2028, assessing data, trends, opportunities and prospects.

Our 188 page report provides 118 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national drug delivery technologies market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2018-2028 and other analyses show you commercial prospects

Besides revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading regional and national markets

How will leading national and regional markets perform to 2028? Our study forecasts revenues in national markets, including:

  • US
  • EU5 (Germany, France, UK, Spain and Italy)
  • Japan
  • China
  • India
  • Brazil
  • Russia
  • South Korea
  • Mexico
  • Rest of the World

Leading companies and potential for market growth

Visiongain forecasts overall revenue for the Drug Delivery Technologies Market will reach $217.7bn in 2018. We predict high revenue growth over the forecast period driven by big pharma seeking diversification of their top-selling products and a growing demand for more patient-friendly treatments in healthcare.

Our work analyses the key companies in the market. See visiongain's analysis of ten leading companies, including:

  • Alkermes
  • 3M
  • Skyepharma
  • Becton Dickinson and Company (BD)
  • Antares Pharma
  • pSivida
  • Applied Pharma Research (APR)
  • Ethypharm
  • Glycologic
  • NanoPass Technologies

A company profile gives you the following information where available:

  • Discussion of a company's activities and outlook including regional and national revenue shares
  • Historic revenue, analysis and discussion of company performance
  • Analysis of major products/services currently available on the market
  • Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the drug delivery technologies industry?

Our new report discusses issues and events affecting the drug delivery technologies market. You will find discussions, including qualitative analyses:

  • Highly fragmented and competitive market with significant variations in different geographic regions
  • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
  • Future opportunities for drug delivery technologies

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Drug Delivery Technologies Market Forecast 2018-2028: Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies report helps you

In summary, our 189-page report gives you the following knowledge:

  • Revenue forecasts to 2028 for the Drug Delivery Technologies market - discover the industry's prospects, finding promising places for investments and revenues
  • Revenue forecasts to 2028 for three major regional markets - US, EU5 and Rest of the World
  • Revenue forecasts to 2028 for the leading national markets - US, Germany, France, UK, Spain, Italy, Japan, China, India, Brazil, Russia, South Korea, Mexico and Rest of the World
  • Assessment of leading companies - analysis of services, business operations, revenue (where available) and mergers & acquisitions
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the drug delivery technologies market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Drug Delivery Technology Market Overview
  • 1.2. Global Drug Delivery Technologies Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who Is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Drug Delivery Technologies: An Introduction

  • 2.1. Drug Delivery Technologies: Strategies to Improve Existing Drugs
  • 2.2. The Global Drug Delivery Technology Market: Methods of Administration
    • 2.2.1. The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
    • 2.2.2. Sustained/Controlled Release Systems
    • 2.2.3. Oral Drug Delivery: Swallowing Drugs to Reach a Target
    • 2.2.4. Pulmonary Delivery: Delivered by Inhalation
    • 2.2.5. Injection as a Route of Drug Delivery
    • 2.2.6. Transdermal Delivery: More Patient-Friendly
    • 2.2.7. Various Transmucosal Delivery Routes for Delivery
    • 2.2.8. Ocular Delivery: Overcoming Unique Barriers
  • 2.3. Regulation in the US
    • 2.3.1. Regulation of Combination Products
    • 2.3.2. FDA Guidelines for Injectors
  • 2.4. Biopharmaceuticals
    • 2.4.1. An Introduction to the Biological Drugs Market
    • 2.4.2. Biologics: A Rising Drugs Market
    • 2.4.3. Biologics with Associated Drug Delivery Technologies
    • 2.4.4. PEGylated Interferons
    • 2.4.5. Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
    • 2.4.6. The Main Challenges Facing Biological Drug Delivery
  • 2.5. Market Definition

3. Drug Delivery Technology: Global Market 2018-2028

  • 3.1. The Global Drug Delivery Technology Market in 2017
  • 3.2. The Global Drug Delivery Technology Market Forecast 2018-2028
  • 3.3. Drug Delivery Technology: Drivers and Restraints 2018-2028
  • 3.4. Biologics: A Driver for Growth in Drug Delivery Technologies
  • 3.4.1. The Global Biological Drugs Market Forecast
    • 3.4.2. Leading Classes of Biological Drugs
    • 3.4.3. Monoclonal Antibodies: Largest Sector in Biologics
    • 3.4.4. Human insulin: Leading the Therapeutic Protein Segment
    • 3.4.5. Interferon Products for the Treatment of Hepatitis
  • 3.5. Vaccines: Meeting the Unmet Needs
    • 3.5.1. The Global Vaccines Market Forecast

4. Drug Delivery Technologies: Submarkets 2018-2028

  • 4.1. The Global Drug Delivery Technology Market by Submarkets
  • 4.2. How Will Segmental Market Shares Change to 2028?
  • 4.3. Oral Drug Delivery Technology
    • 4.3.1. Oral Drug Delivery Technology Market Forecast 2018-2028
    • 4.3.2. Trends and Developments
    • 4.3.3. Oral Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • 4.4. Inhalable Drug Delivery Technology
    • 4.4.1. Inhalable Drug Delivery Technology Market Forecast 2018-2028
    • 4.4.2. Trends and Developments
    • 4.4.3. Inhalable Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • 4.5. Injectable/Implantable Delivery Technology
    • 4.5.1. Injectable/Implantable Delivery Technology Market Forecast 2018-2028
    • 4.5.2. Trends and Developments
    • 4.5.3. Injectable/Implantable Delivery Technologies: Drivers and Restraints 2018-2028
  • 4.6. Transdermal Drug Delivery Technology
    • 4.6.1. Transdermal Drug Delivery Technology Market Forecast 2018-2028
    • 4.6.2. Trends and Developments
  • 4.7. Ocular Drug Delivery Technology
    • 4.7.1. Ocular Drug Delivery Technology Market Forecast 2018-2028
    • 4.7.2. Trends and Developments
  • 4.8. Nasal/Buccal Drug Delivery Technology
    • 4.8.1. Nasal/Buccal Drug Delivery Technology Market Forecast 2018-2028
    • 4.8.2. Trends and Developments

5. Drug Delivery Technologies: Leading National Markets 2018-2028

  • 5.1. Global Drug Delivery Technology Market: Regional Forecast 2018-2028
    • 5.1.1. How Will Regional Market Shares Change to 2028?
  • 5.2. US Drug Delivery Technology Market 2018-2028
    • 5.2.1. US Drug Delivery Technology Market Forecast 2018-2028
    • 5.2.2. Eli Lilly to Establish Drug Delivery Centre
  • 5.3. EU5 Drug Delivery Technology Market 2018-2028
    • 5.3.1. EU5 Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.2. EU5 Drug Delivery Technologies Market: CAGR (%) by Country, 2018-2028
    • 5.3.3. EU5 Markets: Changing Market Shares by Country, 2018-2028
    • 5.3.4. The German Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.5. The French Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.6. The UK Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.7. The Spanish Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.8. The Italian Drug Delivery Technology Market Forecast 2018-2028
  • 5.4. Japanese Drug Delivery Technology Market 2018-2028
    • 5.4.1. Japanese Drug Delivery Technology Market Forecast 2018-2028
    • 5.4.2. The New Sakigake Designation System May Accelerate Innovative Drug Development
  • 5.5. Chinese Drug Delivery Technology Market 2018-2028
    • 5.5.1. Chinese Drug Delivery Technology Market Forecast 2018-2028
  • 5.6. Indian Drug Delivery Technology Market 2018-2028
    • 5.6.1. Indian Drug Delivery Technology Market Forecast 2018-2028
  • 5.7. Brazilian Drug Delivery Technology Market 2018-2028
    • 5.7.1. Brazilian Drug Delivery Technology Market Forecast 2018-2028
  • 5.8. Russian Drug Delivery Technology Market 2018-2028
    • 5.8.1. Russian Drug Delivery Technology Market Forecast 2018-2028
  • 5.9. South Korean Drug Delivery Technology Market 2018-2028
    • 5.9.1. South Korean Drug Delivery Technology Market Forecast 2018-2028
  • 5.10. Mexican Drug Delivery Technology Market 2018-2028
    • 5.10.1. Mexican Drug Delivery Technology Market Forecast 2018-2028
  • 5.11. Rest of the World Drug Delivery Technology Market Forecast 2018-2028

6. Leading Companies in the Drug Delivery Technology Market 2017

  • 6.1. Alkermes: Focused on Extended and Controlled Release
    • 6.1.1. Alkermes PLC
    • 6.1.2. Alkermes PLC: Company Overview
    • 6.1.3. Alkermes PLC: Recent Developments
  • 6.2. 3M
    • 6.2.1. 3M: Company Overview
    • 6.2.2. 3M Company: Product Portfolio
    • 6.2.3. 3M Company: Recent Developments
  • 6.3. Becton, Dickinson & Company: A History of Hypodermic Needles and Syringes
    • 6.3.1. Becton, Dickinson & Company: Company Overview
    • 6.3.2. Becton, Dickinson & Company: Recent Developments
  • 6.4. Intercell AG
    • 6.4.1. Intercell AG: Company Overview
  • 6.5. Altea Therapeutics Corporation
    • 6.5.1. Altea Therapeutics Corporation: Company Overview
  • 6.6. Antares Pharma: Leading the Needle-Free Injector Market
    • 6.6.1. Antares PharmaInc.: Company Overview
    • 6.6.2. Antares Pharma Inc.: Recent Developments
  • 6.7. pSivida:
    • 6.7.1. pSivida Corporation: Company Overview
    • 6.7.2. pSivida Corporation: Recent Developments
  • 6.8. Applied Pharma Research (APR)
    • 6.8.1. Applied Pharma Research S.A.: Company Overview
    • 6.8.2. Applied Pharma Research S.A.: Recent Developments
  • 6.9. Ethypharm
    • 6.9.1. Ethypharm S.A.: Company Overview
  • 6.10. Glycologic
    • 6.10.1. Glycologic Limited: Company Overview
  • 6.11. NanoPass Technologies
    • 6.11.1. NanoPass Technologies Ltd.: Company Overview
    • 6.11.2. NanoPass Technologies Ltd.: Recent Developments

7. Qualitative Analysis of the Drug Delivery Technology Market 2018-2028

  • 7.1. SWOT Analysis of the Drug Delivery Technology Market
  • 7.2. Strengths
    • 7.2.1. Increasing Competition and Patent Expiry in the Biologics Market
    • 7.2.2. The Rise of Biosimilars
    • 7.2.3. Increasing Global Diabetic Population
  • 7.3. Weaknesses
    • 7.3.1. Risk-Conscious Regulatory Bodies Will Make Approval Difficult
    • 7.3.2. Companies Need to Develop a More Liberal Mindset
  • 7.4. Opportunities
    • 7.4.1. Nanotechnology: Innovations That Will Benefit Drug Delivery
    • 7.4.2. Possible New Delivery Methods for Insulin
  • 7.5. Threats
    • 7.5.1. Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
    • 7.5.2. Cost Effective Solutions May Not Be Available

8. Conclusions

  • 8.1. The Global Drug Delivery Technologies Market in 2018
    • 8.1.1. Current Leading Drug Delivery Technology Segments
    • 8.1.2. Notable Drug Delivery Technology Companies
    • 8.1.3. Leading Regional/National Markets
  • 8.2. Global Drug Delivery Technology Market Forecast 2018-2028
  • 8.3. The Future of the Drug Delivery Technology Market
    • 8.3.1. Transdermal and Injectable Drug Delivery Technologies Set For High Growth
    • 8.3.2. Biologics and Biosimilars to Drive Market Growth

9. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1: Global Drug Delivery Technologies Market Segmentation Overview 2018
  • Figure 3.1: The Global Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.2: Drug Delivery Technologies: Market Drivers and Restraints 2018-2028
  • Figure 3.3: Global Biological Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.4: Global Vaccines Market: Revenues ($bn) and AGR (%), 2018-2028
  • Figure 4.1: Leading Drug Delivery Market Segments: CAGR (%), 2018-2022
  • Figure 4.2: Leading Drug Delivery Market Segments: CAGR (%), 2022-2028
  • Figure 4.3: Leading Drug Delivery Market Segments: CAGR (%), 2018-2028
  • Figure 4.4: Market Shares (%) of Leading Drug Delivery Market Segments, 2017
  • Figure 4.5: Market Shares (%) of Leading Drug Delivery Market Segments, 2022
  • Figure 4.6: Market Shares (%) of Leading Drug Delivery Market Segments, 2028
  • Figure 4.7: Oral Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.8: Oral Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • Figure 4.9: Inhalable Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.10: Inhalable Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • Figure 4.11: Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.12: Injectable/implantable Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • Figure 4.13: Transdermal Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.14: Ocular Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.15: Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.1: The Global Drug Delivery Technologies Market by Country/Region: Revenue ($bn), 2018
  • Figure 5.2: Global Drug Delivery Technology Market: Revenue ($bn) by Country/Region, 2018, 2022 and 2028
  • Figure 5.3: Global Drug Delivery Technology Market: CAGR (%) by Country/Region, 2018-2022
  • Figure 5.4: Global Drug Delivery Technology Market: CAGR (%) by Country/Region, 2022-2028
  • Figure 5.5: Global Drug Delivery Technology Market: CAGR (%) by Country/Region 2018-2028
  • Figure 5.6: Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2017
  • Figure 5.7: Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2022
  • Figure 5.8: Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2028
  • Figure 5.9: US Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.10: EU5 Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.11: EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2022
  • Figure 5.12: EU5 Drug Delivery Technology Market: by Country, 2022-2028
  • Figure 5.13: EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2028
  • Figure 5.14: EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2017
  • Figure 5.15: EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2022
  • Figure 5.16: EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2028
  • Figure 5.17: German Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.18: French Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.19: UK Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.20: Spanish Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.21: Italian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.22: Japanese Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.23: Chinese Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.24: Indian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.25: Brazilian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.26: Russian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.27: South Korean Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.28: Mexican Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.29: Rest of the World Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.1: Alkermes PLC, Revenue, ($million), 2012-2016
  • Figure 6.2: Alkermes PLC, Geographical Presence Share (%), 2016
  • Figure 6.3: 3M, Revenue, ($million), 2012-2016
  • Figure 6.4: 3M, Product Segments Share (%), 2016
  • Figure 6.5: 3M, Geographical Presence Share (%), 2016
  • Figure 6.6: Becton, Dickinson & Company, Revenue, ($million), 2013-2017
  • Figure 6.7: Becton, Dickinson & Company, Geographical Presence Share (%), 2017
  • Figure 6.8: Becton, Dickinson & Company, Segment Share (%), 2017
  • Figure 6.9: Antares Pharma Inc., Revenue, ($million), 2013-2017
  • Figure 6.10: 6pSivida Corporation, Revenue, ($million), 2012-2016
  • Figure 6.11: pSivida Corporation, Product Segments Share (%), 2016
  • Figure 6.12: Ethypharm S.A., Revenue, ($million), 2012-2016

List of Tables

  • Table 1.1: Global Drug Delivery Technologies Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Region, 2018-2028 (Redacted Data)
  • Table 2.1: The Biopharmaceutics Classification System, Classification and Description
  • Table 2.2: Top 5 Biologics by Sales ($bn), 2018
  • Table 3.1: The Global Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.2: Global Biological Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.3: Global Vaccines Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.1: The Global Drug Delivery Technology Market by Submarkets: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.2: Leading Drug Delivery Market Segments: Share (%), 2017, 2022, and 2028
  • Table 4.3: Leading Drug Delivery Market Segments: Market Share (%), 2017
  • Table 4.4: Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.5: Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.6: Insulin Inhalers Withdrawal from the Market or Pipeline, 2017
  • Table 4.7: Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.8: Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.9: Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.10: Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.1: The Global Drug Delivery Technologies Market by Country/Region: Revenue ($bn) and Market Share (%), 2017
  • Table 5.2: Global Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Country/Region, 2018-2028
  • Table 5.3: Global Drug Delivery Technology Market: Revenue ($bn) by Country/Region, 2018, 2022 and 2028
  • Table 5.4: Global Drug Delivery Technology Market: Revenue ($bn) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Table 5.5: US Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.6: EU5 Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.7: EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2022, 2022-2028 and 2018-2028
  • Table 5.8: EU5 Drug Delivery Technology Market: Market Size ($bn) and Market Share (%) by Country, 2017, 2022 and 2028
  • Table 5.9: German Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.10: French Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.11: UK Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.12: Spanish Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.13: Italian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.14: Japanese Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.15: Chinese Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.16: Indian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.17: Brazilian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Table 5.18: Russian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.19: South Korean Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.20: Mexican Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.21: Rest of the World Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.1: Akermes PLC: Company Overview
  • Table 6.2: Alkermes PLC: Recent Developments
  • Table 6.3: 3M: Company Overview
  • Table 6.4: 3M: Product Portfolio
  • Table 6.5: 3M Company: Recent Developments
  • Table 6.6: Becton, Dickinson & Company: Company Overview
  • Table 6.7: Becton, Dickinson & Company: Recent Developments
  • Table 6.8: Intercell AG: Company Overview
  • Table 6.9: Altea Therapeutics Corporation: Company Overview
  • Table 6.10: Antares Pharma Inc.: Company Overview
  • Table 6.11: Antares Pharma Inc.: Recent Developments
  • Table 6.12: pSivida Corporation: Company Overview
  • Table 6.13: pSivida Corporation: Recent Developments
  • Table 6.14: Applied Pharma Research S.A.: Company Overview
  • Table 6.15: Applied Pharma Research S.A.: Recent Developments
  • Table 6.16: Ethypharm S.A.: Company Overview
  • Table 6.17: Glycologic Limited: Company Overview
  • Table 6.18: NanoPass Technologies Ltd.: Company Overview
  • Table 6.19: NanoPass Technologies Ltd.: Recent Developments
  • Table 7.1: SWOT Analysis of the Drug Delivery Technology Market, 2018-2028

Companies Listed

  • 3M
  • Acorda
  • Actavis
  • Adamis
  • Aleza Pharmaceuticals
  • Alkermes
  • Almirall
  • Alza
  • Antares Pharma
  • Applied Pharma Research
  • Aradigm
  • Astellas
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • BD
  • Biogen
  • BioGeneration Ventures
  • Bioject Medical Technologies
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • CareFusion Corporation
  • Cephalon
  • Changchun BCHT
  • Chiesi
  • Chrono Therapeutics
  • Cilag
  • Cima Labs
  • Clearside
  • Cosmo Pharmaceuticals
  • CRISI Medical Systems
  • CTCBIO
  • Daiichi
  • Elan Drug Technologies
  • Elcam Medical
  • Eli Lilly
  • Ethypharm
  • Ferrer
  • Ferring
  • Flamel
  • Genentech
  • GlaxoSmithKline
  • Glycologic
  • Google
  • GSK
  • Haselmeir
  • Horizon Pharma
  • ImmusanT
  • Innovent Biologics
  • Insmed
  • Invion
  • iScience Interventional Corporation
  • J&J
  • Janssen
  • JCR Pharmaceuticals
  • Kyorin
  • MannKind
  • Meda Pharmaceuticals
  • Medac
  • Medimetrics
  • MedImmune
  • MedSciences Capital
  • Merck Serono
  • Mucosis
  • Mundipharma
  • Nanopass Technologies
  • Nektar Therapeutics
  • Nexvax2
  • NHTherapeutics
  • Novartis
  • Novo Nordisk
  • NuPathe
  • NV NOM
  • Oramed
  • OwenMumford
  • Pacira Pharmaceuticals
  • Pari Pharma
  • Permatec
  • Pfizer
  • PharmaJet
  • Presspart
  • ProStrakan
  • pSivida
  • Pulmagen
  • Ranbaxy
  • Rani Therapeutics
  • Recro Pharma
  • Regeneron Pharmaceuticals
  • Roche
  • Sandoz
  • Sanofi-Aventis
  • Santen
  • Shionogi
  • SHL Group
  • Shreya Life Sciences
  • Skyepharma
  • Smoofi
  • Spark Therapeutics
  • STADA Arzneimittel
  • Takeda
  • Teva
  • UU Holdings
  • Vetter Pharma
  • West Pharmaceuticals
  • Ypsomed

List of Organizations:

  • European Medicines Agency (EMA)
  • Ministry of Health, Labor and Welfare (MHLW)
  • The Centers for Disease Control and Prevention (CDC)
  • The Organisation for Economic Co-operation and Development (OECD)
  • UK National Health Service (NHS)
  • US Food & Drug Administration (FDA)
  • World Health Organisation (WHO)
Back to Top